TENX – tenax therapeutics, inc. (US:NASDAQ)
Stock Stats
News
12/2
03:46 pm
tenx
Low
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/25
01:57 pm
tenx
Low
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/25
08:01 am
tenx
Low
Tenax Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/25
07:00 am
tenx
Low
Tenax Therapeutics to Participate in Upcoming Investor Conferences
11/13
09:36 pm
tenx
Low
Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript [Seeking Alpha]
11/20
06:39 pm
tenx
Medium
Form 4 TENAX THERAPEUTICS, INC. For: Nov 18 Filed by: Giordano Christopher Thomas
11/20
06:17 pm
tenx
Medium
Form 4/A TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
11/19
07:02 pm
tenx
Medium
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: MCGAULEY THOMAS
11/19
06:44 pm
tenx
Medium
Form 4 TENAX THERAPEUTICS, INC. For: Nov 17 Filed by: Almenoff June Sherie
11/14
05:39 pm
tenx
Medium
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
Show more
Top News Gainers
10/31 Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial 7.4%
1/15 Tenax Therapeutics Inc (NASDAQ: TENX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%
6/14 Form 8-K TENAX THERAPEUTICS, INC. For: Jun 13 4.7%
1/22 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.3%
8/23 Tenax Therapeutics Provides Clinical Development Update 3.4%
8/30 Form S-8 TENAX THERAPEUTICS, INC. 2.5%
11/8 Form 8-K/A TENAX THERAPEUTICS, INC. For: Jun 13 2.5%
4/29 Form 8-K TENAX THERAPEUTICS, INC. For: Apr 24 2.3%
3/30 Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31 2.1%
2/14 Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Iroquois Capital Management, LLC 0.0%
Top News Decliners
3/13 Form 8-K TENAX THERAPEUTICS, INC. For: Mar 11 -35.8%
2/29 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.8%
1/13 Form 8-K TENAX THERAPEUTICS, INC. For: Jan 13 -7.9%
4/9 Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction -6.7%
2/21 Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board -5.8%
2/7 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock Inc. -5.7%
3/27 Form D TENAX THERAPEUTICS, INC. -5.6%
5/15 Q1/2019 3/31/2019 EPS -0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.2%
8/14 Q2/2019 6/30/2019 EPS -0.280 ZacksConsensus -0.450 ActVsEst 0.170 - Beat -4.2%
3/23 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC -2.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3